VolitionRX Limited (VNRX)
(Delayed Data from AMEX)
$0.66 USD
+0.03 (3.94%)
Updated Sep 20, 2024 03:53 PM ET
After-Market: $0.66 0.00 (0.00%) 6:34 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
VolitionRX Limited [VNRX]
Reports for Purchase
Showing records 21 - 40 ( 100 total )
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2017 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Positive Interim Readout for Pre-Cancer and Early-Stage CRC Detection; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Danish Logistics and Pathway Design Study Concluded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Frontline Asymptomatic CRC Screening Test Result in the Immediate Term; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Sale of Nu.Q Research Kits Signifies Potential Licensing Opportunities; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Frontline CRC Screening Test May Enter EU Market in 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2017 2Q Financial Results Reported; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2017 2Q Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Participation in Colorectal Cancer (CRC) Screening Trial With Minimal Investment; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Participation in Colorectal Cancer (CRC) Screening Trial With Minimal Investment; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Colorectal Cancer Screening Alternatives: Emerging Investment Opportunities
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Colorectal Cancer Screening Alternatives: Emerging Investment Opportunities
Provider: H.C. Wainwright & Co., Inc.